Meet the editor

Professor Dr. Shailendra K. Saxena is a vice dean and professor at King George's Medical University, Lucknow, India. His research interests involve understanding the molecular mechanisms of host defense during human viral infections and developing new predictive, preventive, and therapeutic strategies for them using Japanese encephalitis virus (JEV), HIV, and emerging viruses as a model via stem cell and cell culture technologies. His research

work has been published in various high-impact factor journals (*Science, PNAS, Nature Medicine*) with a high number of citations. He has received many awards and honors in India and abroad including various Young Scientist Awards, BBSRC India Partnering Award, and Dr. JC Bose National Award of Department of Biotechnology, Min. of Science and Technology, Govt. of India. Dr. Saxena is a fellow of various prestigious international societies/academies including the Royal College of Pathologists, United Kingdom; Royal Society of Medicine, London; Royal Society of Biology, United Kingdom; Royal Society of Chemistry, London; and Academy of Translational Medicine Professionals, Austria. He was named a Global Leader in Science by *The Scientist*. He is also an international opinion leader/expert in vaccination for Japanese encephalitis by IPIC (UK).

Contents

**Section 1**

**Section 2**

**Preface XV**

Drug Repurposing for Infectious Diseases **1**

**Chapter 1 3**

Drug Repurposing for Antiviral Drug Discovery **15**

**Chapter 2 17**

**Chapter 3 35**

Drug Repurposing for Antibacterial Drug Discovery **63**

**Chapter 4 65**

**Chapter 5 103**

Antituberculosis Drug Repurposing: A New Hope for Tackling

*by Shahnawaz Majeed, Safiya Mehraj and Zahoor Ahmad*

*by Nicole C. Cardoso, Carel B. Oosthuizen, Nashied Peton* 

Trends in Molecular Aspects and Therapeutic Applications

Evaluation of Drug Repositioning by Molecular Docking of Pharmaceutical Resources to Identification of Potential

*by Fatemeh Hosseini, Mehrdad Azin, Hamideh Ofoghi* 

Drug Repurposing Techniques in Viral Diseases *by Ran Zhang, Rick Oerlemans, Chao Wang, Lili Zhang* 

Multi-Challenging TB in Timely Manner

Drug Repurposing for Tuberculosis

of Drug Repurposing for Infectious Diseases *by Ankur Gupta, Angila Theengh, Swatantra Kumar, Vimal K. Maurya, Santosh Kumar, Bipin Puri* 

*and Shailendra K. Saxena*

*SARS-CoV-2* Viral Inhibitors

*and Tahereh Alinejad*

*and Matthew R. Groves*

*and Vinayak Singh*

**Section 3**
